About Thorium Norway AS
Thorium Norway AS was established in 2015 with the goal of developing new industries to meet the growing demand for the element Thorium (Th 232).
With around 150+ private investors, the company has formed a project group focused on creating a significant industrial venture.
Our mission is to transform thorium-containing mining waste from the Fen area and other sources around the world into valuable products for the nuclear power and pharmaceutical industries.
Latest News and Insights
Thorium’s Role in Energy and Medicine: Insights from Olav Albert Aasbø Jr.
October 4, 2024
Thorium Norway chairman discusses Fensfeltet thorium deposits' potential for cancer treatment and nuclear energy, highli...
Billion NOK Investment in New Factory Facilities - Press Release
July 2, 2024
Thorium Norway AS plans billion NOK investment in new factory facilities, targeting 1200 tons annual production of thori...
NAAREA & Thorizon Join Forces, Bringing New Reactors to Europe
February 24, 2024
NAAREA (France) and Thorizon (Netherlands) partner to develop thorium-powered Molten Salt Reactors, advancing nuclear in...
Products and Services
Thorium Norway AS, in collaboration with Bilfinger Tebodin Netherlands and Thor Energy AS, has developed a factory concept to produce eight products targeting the nuclear power and pharmaceutical markets.
Our factory is designed to handle approximately 1,200 tons of finished products annually, responsibly managing all low-radioactive materials from the Fen area.
Industry Impact
Our thorium-based research contributes to advancements in nuclear energy technology and medical applications. Through our development work, we aim to improve fuel efficiency and reduce waste in nuclear power generation.
Our focus includes the development of thorium-derived materials for medical applications, particularly in targeted therapies for cancer treatment.
